Glaucoma Surgery

Glaucoma is one of the leading causes of irreversible sight loss worldwide, with a prevalence of 64.3 million in 2013 and an estimated increase to 111.8 million by 2040 [1]. The initial treatment for glaucoma usually comprises topical medication, but further procedures depend on the type of glaucoma, disease stage and severity, and several individual factors, including age, life expectancy, treatment adherence, quality of life, and both patients’ and clinicians’ personal choices. Irrespective of all these factors, surgical intervention may still be required in those patients with significant progression and uncontrolled disease despite maximum medical therapy.